Mastering Modified Release: The Pellet-Based Approach
Explore how pellet-based systems can de-risk development and scale-up of robust modified-release formulations across the product lifecycle.
oral dosage forms
LGM Pharma Boosts US Manufacturing with Additional $9 Million Investment
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Sharp Services Invests $100 Million in US and European Facilities
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cyprumed and MSD Enter Licensing Agreement for Oral Peptide Therapeutics
MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.
Adare to Expand Oral Dose Capabilities in Italy
US CDMO Adare Pharma Solutions is to add a high-shear mixer granulator at its Pessano, Italy facility, to complement existing fluid bed capabilities. The new mixer can provide wet granulation using either aqueous or organic-based solutions.
Hovione Expands Continuous Manufacturing Capabilities
Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers a commercial continuous tableting platform to support their key needs.
